CDX-modified chitosan nanoparticles remarkably reduce therapeutic dose of fingolimod in the EAE model of mice.
Sepasi T, Ghadiri T, Ebrahimi-Kalan A, Bani F, Talebi M, Rahbarghazi R, Khodakarimi S, Beyrampour-Basmenj H, Seidi K, Abbaspour-Ravasjani S, Sadeghi MR, Zarebkohan A, Gao H.
Sepasi T, et al.
Int J Pharm. 2023 Apr 5;636:122815. doi: 10.1016/j.ijpharm.2023.122815. Epub 2023 Mar 11.
Int J Pharm. 2023.
PMID: 36907279